Prerequisites for human papillomavirus vaccine trial: results of feasibility studies

This publication has 10 references indexed in Scilit:

• Attack rates of human papillomavirus type 16 and cervical neoplasia in primiparous women and field trial designs for HPV16 vaccination
  Sexually Transmitted Infections, 2000
• Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: Recent increase in cervical cancer incidence
  International Journal of Cancer, 1999
• Prospective study on cervical neoplasia IV. Presence of HPV antibodies
  International Journal of Cancer, 1999
• Stability over Time of Serum Antibody Levels to Human Papillomavirus Type 16
  The Journal of Infectious Diseases, 1998
• Natural History of Cervicovaginal Papillomavirus Infection in Young Women
  New England Journal of Medicine, 1998
• Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer
  JNCI Journal of the National Cancer Institute, 1997
• Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction
  Cancer, 1996
• Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study
  BMJ, 1996
• Human Papillomavirus Infection Is Transient in Young Women: A PopulationBased Cohort Study
  The Journal of Infectious Diseases, 1995
• Prevalence, Incidence, and Estimated Life-time Risk of Cervical Human Papillomavirus Infections in a Nonselected Finnish Female Population
  Sexually Transmitted Diseases, 1990